Insight Molecular Diagnostics Ownership | Who Owns Insight Molecular Diagnostics?

Overview Forecast RevenueFinancials Chart Transcripts

Insight Molecular Diagnostics Ownership Summary

Insight Molecular Diagnostics is owned by 7.16% institutional investors, 20.02% insiders, and 72.83% retail investors. Broadwood capital is the largest institutional shareholder, holding 39.15% of IMDX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.47% of its assets in Insight Molecular Diagnostics shares.

IMDX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Insight Molecular Diagnostics	7.16%	20.02%	72.83%
Sector	Healthcare Stocks	50.44%	12.38%	37.18%
Industry	Diagnostics & Research Stocks	77.65%	9.11%	13.24%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Broadwood capital	11.93M	39.15%	$39.14M
Awm investment company	2.81M	9.21%	$9.20M
Pura vida investments	947.13K	3.11%	$3.11M
Geode capital management	262.05K	0.86%	$860.17K
Fny investment advisers	247.42K	0.81%	$811.00K
Blackrock funding, inc. /de	135.34K	0.44%	$443.93K
Vanguard fiduciary trust	132.59K	0.44%	$434.90K
Family office research	127.27K	0.42%	$417.43K
Millennium management	103.47K	0.34%	$339.38K
State street	50.75K	0.17%	$166.47K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pura vida investments	947.13K	20.88%	$3.11M
Broadwood capital	11.93M	2.76%	$39.14M
Awm investment company	2.81M	1.02%	$9.20M
Fny investment advisers	247.42K	0.35%	$811.00K
Family office research	127.27K	0.18%	$417.43K
Xtx topco	30.35K	0.00%	$99.56K
Eversource wealth advisors	27.00	0.00%	$7.85K
Private advisor group	10.42K	0.00%	$34.16K
Piscataqua savings bank	25.00	0.00%	$81.00
Millennium management	103.47K	0.00%	$339.38K

Top Buyers

Holder	Shares	% Assets	Change
Broadwood capital	11.93M	2.76%	521.74K
Fny investment advisers	247.42K	0.35%	206.84K
Vanguard fiduciary trust	132.59K	0.00%	132.59K
Family office research	127.27K	0.18%	127.27K
Millennium management	103.47K	0.00%	42.09K

Top Sellers

Holder	Shares	% Assets	Change
Alyeska investment group	-	-	-840.78K
Heights capital management	-	-	-392.55K
Ghisallo capital management	-	-	-70.69K
Susquehanna group, llp	-	-	-56.09K
Jane street group	-	-	-42.47K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	132.59K	0.00%	132.59K	$434.90K
Family office research	127.27K	0.18%	127.27K	$417.43K
Xtx topco	30.35K	0.00%	30.35K	$99.56K
Vanguard global advisers	5.78K	-	5.78K	$18.94K
Cassaday & co wealth management	10.00	-	10.00	$33.00

Sold Out

Holder	Change
Federation des caisses desjardins du quebec	-1.00
Tower research capital llc (trc)	-250.00
Golden state equity partners	-450.00
Citigroup	-815.00
Advisory services network	-3.10K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	20	-41.18%	2,180,616	-86.90%	7	0.26%	14	-12.50%	-	-100.00%
Dec 31, 2025	34	25.93%	16,651,600	2.26%	51	2.01%	16	77.78%	7	-
Sep 30, 2025	27	-10.00%	16,282,884	6.65%	50	2.24%	9	-43.75%	7	16.67%
Jun 30, 2025	30	3.45%	15,267,294	-4.86%	47	1.22%	16	-5.88%	6	20.00%
Mar 31, 2025	29	16.00%	16,047,858	91.76%	62	2.69%	17	13.33%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	475.40K	1.47%	-
Vanguard Morn Total Stk Mkt Idx Investor	475.40K	1.47%	-
Vanguard Institutional Extnd Mkt Idx Tr	248.06K	0.77%	-
Fidelity Extended Market Index	112.75K	0.35%	-3.07K
Extended Equity Market Fund B	54.35K	0.17%	43.70K
Extended Equity Market Fund E	54.35K	0.17%	43.70K
Blackrock Extended Mkt Fund CF	54.35K	0.17%	-
BlackRock Extended Equity Market Fund K	46.19K	0.14%	-85.00
iShares Micro-Cap ETF	42.69K	0.13%	-570.00
Fidelity Total Market Index	38.65K	0.12%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 24, 2026	BROADWOOD PARTNERS, L.P.	-	Buy	$137.08K
Apr 24, 2026	BROADWOOD PARTNERS, L.P.	-	Buy	-
Apr 27, 2026	BROADWOOD PARTNERS, L.P.	-	Buy	$913.13K
Apr 27, 2026	BROADWOOD PARTNERS, L.P.	-	Buy	-
Apr 23, 2026	BROADWOOD PARTNERS, L.P.	-	Buy	$982.03K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	12	-
2026 Q1	2	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q1	13	-

IMDX Ownership FAQ

Who Owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics shareholders are primarily institutional investors at 7.16%, followed by 20.02% insiders and 72.82% retail investors. The average institutional ownership in Insight Molecular Diagnostics's industry, Diagnostics & Research Stocks, is 77.65%, which Insight Molecular Diagnostics falls below.

Who owns the most shares of Insight Molecular Diagnostics?

Insight Molecular Diagnostics’s largest shareholders are Broadwood capital (11.93M shares, 39.15%), Awm investment company (2.81M shares, 9.21%), and Pura vida investments (947.13K shares, 3.11%). Together, they hold 51.47% of Insight Molecular Diagnostics’s total shares outstanding.

Does Blackrock own Insight Molecular Diagnostics?

BlackRock is not among the top 10 institutional shareholders of Insight Molecular Diagnostics.

Who is Insight Molecular Diagnostics’s biggest shareholder by percentage of total assets invested?

Pura vida investments is Insight Molecular Diagnostics’s biggest shareholder by percentage of total assets invested, with 20.88% of its assets in 947.13K Insight Molecular Diagnostics shares, valued at 3.11M$.

Who is the top mutual fund holder of Insight Molecular Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Insight Molecular Diagnostics shares, with 1.47% of its total shares outstanding invested in 475.4K Insight Molecular Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools